FDA Adverse Event Malfunction Summary report: N

ELECSYS ANTI-HBS II

MDR report key: 21393274 · Received February 18, 2025

Report

Report Number
1823260-2025-00451
Event Type
Malfunction
Date Received
February 18, 2025
Date of Event
January 23, 2025
Report Date
March 17, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LOM
PMA / PMN Number
P010054
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

IN THE INITIAL MEDWATCH, THE FIRST LINE OF B5 DESCRIBE EVENT OR PROBLEM SHOULD HAVE BEEN: "THE INITIAL REPORTER RECEIVED A QUESTIONABLE ELECSYS ANTI-HBS II RESULT FROM ONE PATIENT SAMPLE TESTED ON THE COBAS 8000 - COBAS E 602 MODULE." INSTEAD OF: "THE INITIAL REPORTER RECEIVED A QUESTIONABLE ELECSYS ANTI-HBS II RESULT FROM ONE PATIENT SAMPLE TESTED ON THE COBAS 8000 - COBAS E 602 MODULE OR A COBAS E 601 MODULE." THE QC WAS WITHIN SPECIFICATIONS. A GENERAL REAGENT ISSUE CAN BE EXCLUDED. BASED ON THE INFORMATION PROVIDED, THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.

Additional Manufacturer Narrative · 0

THE SERIAL NUMBER OF THE COBAS 8000 - COBAS E 602 MODULE IS 1207-02. THERE WAS NO SERIAL NUMBER PROVIDED FOR A COBAS E 601 MODULE. THE INVESTIGATION IS ONGOING.

Description of Event or Problem · 0

THE INITIAL REPORTER RECEIVED A QUESTIONABLE ELECSYS ANTI-HBS II RESULT FROM ONE PATIENT SAMPLE TESTED ON THE COBAS 8000 - COBAS E 602 MODULE OR A COBAS E 601 MODULE. THE RESULT FROM THE E 602 OR E 601 MODULE WAS 7.91 IU/L OR 7.96 IU/L. THIS RESULT WAS DEEMED A FALSE NEGATIVE. THE RESULT FROM AN E 801 MODULE WAS 39.1 IU/L. THE REPORTER STATED THAT BOTH RESULTS WERE REPEATABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1205582 ELECSYS ANTI-HBS II TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) LOM ROCHE DIAGNOSTICS 80423001

Patients

Seq Age Sex Outcome Treatment
1 37 YR Female